Edition:
United States

Tabula Rasa HealthCare Inc (TRHC.OQ)

TRHC.OQ on NASDAQ Stock Exchange Global Market

71.52USD
4:00pm EDT
Change (% chg)

$2.70 (+3.92%)
Prev Close
$68.82
Open
$69.37
Day's High
$71.74
Day's Low
$68.95
Volume
146,100
Avg. Vol
108,903
52-wk High
$71.74
52-wk Low
$16.81

Summary

Name Age Since Current Position

Calvin Knowlton

67 2014 Chairman of the Board, Chief Executive Officer, Co-Founder

Orsula Knowlton

49 2014 President, Co-Founder, Director

Brian Adams

36 2018 Chief Financial Officer and Principal Financial Officer

Andrea Speers

37 2018 Principal Accounting Officer

Samira Beckwith

64 2017 Director

Jan Berger

61 2018 Independent Director

Dennis Helling

68 2017 Independent Director

Michael Purcell

61 2018 Independent Director

A. Gordon Tunstall

73 2014 Independent Director

Biographies

Name Description

Calvin Knowlton

Dr. Calvin H. Knowlton, Ph.D. serves as Chairman of the Board, Chief Executive Officer, Co-Founder of the Company. He has served as Chairman and Chief Executive Officer of CareKinesis since May 2009. Dr. Calvin Knowlton founded excelleRx Inc., a national hospice medication management pharmacy serving the elderly, where he acted as President and Chief Executive Officer from April 1995 through July 2007. Dr. Calvin Knowlton has served on the Board and Executive Committee of the Coriell Institute for Medical Research since 2009, and the Evergreens Continuing Care Retirement Community Board of Trustees since 2011. He is the incoming Board Chair of the Evergreens Retirement Community effective as of January 1, 2017, has chaired the Board of Coriell Life Sciences, Inc. since 2011 and has served as a founding member of the Board of the Cooper Medical School of Rowan University since 2011. Dr. Calvin Knowlton served on the Board of St. Christopher’s Hospital for Children in Philadelphia from 2005 to 2011. Dr. Calvin Knowlton has been a member of the APhA Pharmacogenomics Task Force, as well as the national Pharmacogenomics Advisory Group since 2010 and 2011, respectively. Dr. Calvin Knowlton served as President of the American Pharmacists Association from 1994 to 1996, and President of the American Pharmacist Association Foundation from 2008 to 2009. Dr. Calvin Knowlton was awarded the highest national honor in pharmacy, the Remington Honor Medal, in 2015. Dr. Calvin Knowlton received his pharmacy degree from Temple University, his Divinity degree from Princeton Theological Seminary and his Ph.D. in Pharmacoeconomics from the University of Maryland.

Orsula Knowlton

Dr. Orsula Voltis Knowlton serves as President, Co-Founder, Director of the Company. She has served as President and a director of CareKinesis since May 2009. She served in numerous positions, including Vice President and Chief Marketing, New Business Development and Strategy Officer, of excelleRx, Inc. from April 1995 through July 2007. Dr. Orsula Knowlton currently serves on the Board of Trustees, a position she has held since 2009, and has chaired the Quality Committee for Samaritan Hospice, Marlton, NJ since 2012. She has been a member of the Board of Trustees for the West Jersey Chamber Music Society from 2009. Dr. Orsula Knowlton served on the Dean’s Advisory Board, School of Public Health, Drexel University, Philadelphia from 2008 through 2011; the founding Dean’s Advisory Board of Jefferson School of Pharmacy, Philadelphia, PA from 2009 through 2012; the Board of Advisors for the George Washington Institute on Spirituality and Health, Washington, DC from 2009 through 2012; and the Board of Trustees for Family Services, Mt. Holly, NJ (Oaks Integrated Care) from 2009 through 2012. Dr. Orsula Knowlton graduated from the University of the Sciences School of Pharmacy and Temple University’s executive Masters in Business Administration program.

Brian Adams

Mr. Brian W. Adams is Chief Financial Officer and Principal Financial Officer of the Company. From September 2007 through October 2011, Mr. Adams served as Senior Financial Analyst, Manager of Finance and Associate Director of Finance and Accounting at KPMG LLP. Mr. Adams served as the Manager of Financial Planning and Analysis of excelleRx, Inc. from July 2005 through September 2007. Mr. Adams graduated from The University of Richmond, Robins School of Business with a Bachelor of Science in Business Administration with a concentration in finance.

Andrea Speers

Ms. Andrea C. Speers is Principal Accounting Officer of the company. She has been the Company’s Corporate Controller since September 2015 and, prior thereto, served in a variety of roles with the Company and its predecessor, CareKinesis, Inc., with increasing levels of responsibility including Accounting Manager from February 2012 through March 2014 and Director of Accounting Operations from March 2014 through September 2015. Prior to joining CareKinesis, Inc., Ms. Speers served as a senior financial analyst at KPMG LLP from February 2008 through February 2012. Ms. Speers holds a Bachelor of Business Administration in Accounting from St. Mary’s University and a Masters in Accounting from the University of Texas at San Antonio.

Samira Beckwith

Dr. Samira K. Beckwith is Director of the company. She has been President and Chief Executive Officer of Hope HealthCare Services, a holistic health care system providing care for over 3,000 individuals daily, since 1991. Over the course of her career, Dr. Beckwith has actively worked with many professional organizations dedicated to hospice and palliative care, serving on the Board of Directors of the Florida Hospice and Palliative Care Association since 1991, the Board of Directors of the Hospice Action Network since 2007, the Board of Directors of the National PACE Association since 2013 and the National Advisory Board of the CSU Institute for Palliative Care since 2015, among others. She is the Founding President of the Florida PACE Association and a Founding Director of the National Partnership for Hospice Innovation. Dr. Beckwith has also served as a director of Investor’s Security Trust since 2003. Dr. Beckwith received a Doctor of Humane Letters from Southwest Florida College and holds a Bachelor of Sociology Degree and a Masters in Social Work from The Ohio State University. The Board believes that Dr. Beckwith’s commitment to quality care and experience with palliative care and end of life issues will make her a valuable member of the Company’s Board.

Jan Berger

Dr. Jan Berger is Independent Director of the Company. Dr. Berger is Founder, President and Chief Executive Officer of Health Intelligence Partners, a global healthcare consultancy that advises clients on areas of growth. Previously, Dr. Berger was Senior Vice President, Chief Clinical Officer and Innovation Officer for CVS Health/Caremark. Dr. Berger has worked for a number of healthcare and consumer product boards and currently serves on the Board of Directors of Cambia Health Solutions, AccentCare, Inc. and GNS Healthcare. Dr. Berger earned a Doctor of Medicine and a Master's in Jurisprudence from Loyola University Chicago.

Dennis Helling

Dr. Dennis K. Helling, PharmD serves as Independent Director of the Company. Dr. Helling has been a Clinical Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences since 1992. From 1992 until January 2013, Dr. Helling served as the Executive Director of Pharmacy Operations and Therapeutics at Kaiser Permanente Colorado, a nonprofit health maintenance organization that develops innovative pharmacy services. In 1979, Dr. Helling co-founded the American College of Clinical Pharmacy, an international association of clinical pharmacists dedicated to optimizing drug therapy outcomes in patients, and served as President from 1997 through 1998. Dr. Helling also served as President of the Accreditation Council for Pharmacy Education, a national agency responsible for the accreditation of professional degree programs in pharmacy, from 2002 through 2004 and the American Pharmacists Association Foundation, a nonprofit organization whose mission is to improve health by inspiring philanthropy, research, and innovation that advances pharmacists’ patient care services, from 2010 through 2012. Over his career, Dr. Helling has been actively involved in hospice and palliative care, serving on the boards of Care Synergy since 2015 and as Vice-Chair of The Denver Hospice Board of Directors since 2009. Dr. Helling has also chaired the Working Group on Pharmacy Reimbursement in the Federation of International Pharmacy. Dr. Helling currently serves on the American Pharmacists Association Board of Trustees and Pharmacy Specialties Board of Directors. Dr. Helling earned a BSPharm from the St. Louis College of Pharmacy, a PharmD from the University of Cincinnati College of Pharmacy and completed his residency at Cincinnati General Hospital. Dr. Helling was awarded the highest national honor in pharmacy, the Remington Honor Medal, in 2013.

Michael Purcell

Mr. Michael J. Purcell is Independent Director of the Company. He has been a Value Creation Partner and Consultant at New Spring Capital since January 2016. Mr. Purcell has more than 37 years of professional experience with Deloitte & Touche LLP, serving as a consultant from August 2015 to January 2017 and an Audit Partner from 1979 until August 2015. Mr. Purcell also currently serves as a financial advisor to several emerging growth companies. Mr. Purcell is a certified public accountant and has provided assurance and advisory services to public and private enterprise clients of all sizes over the course of his career. Mr. Purcell has worked on a number of company boards and has served on the Board of Directors of Capital Funding Bancorp, Inc. since 2016, the Board of Directors of McKean Defense Group since 2017, the Board of Directors of ESF Camps since 2017, the Board of Directors of Hyperion Bank since 2018, and the Board of Directors of Code 3 Emergency Partners since 2018. Mr. Purcell also sits on the boards of numerous academic and community organizations. Mr. Purcell earned a Master’s in Business Administration from Drexel University and holds a Bachelor of Science from Lehigh University. The Board believes that Mr. Purcell’s extensive finance and audit experience will make him a valuable member of the Company’s Board.

A. Gordon Tunstall

Mr. A. Gordon Tunstall is Independent Director of the Company. Mr. Tunstall founded Tunstall Consulting, Inc. in 1980, which provides entrepreneurs with advisory services developing growth capital in the institutional capital markets. Mr. Tunstall has served as director on several boards, including excelleRx, Inc., Kforce Inc., Health Insurance Innovations, Inc., Advanced Lighting Technologies, Inc., JLM Industries, Inc., Horizon Medical Products, Inc., Discount Auto Parts, Inc., L.A.T. Sportswear and OrthoSynetics, Inc. (formerly Orthodontic Centers of America, Inc.). Mr. Tunstall is a CPA. Mr. Tunstall attended Widener College and received a Bachelor of Science in accounting.

Basic Compensation